Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board

Spinogenix said Prof. Coyle will provide guidance on the company’s neuroscience pipeline, with emphasis on its schizophrenia program. The update is framed as informational on pipeline direction rather than including any quantified efficacy, safety, or financial targets.

Analysis

Spinogenix said Prof. Coyle will provide guidance on the company’s neuroscience pipeline, with emphasis on its schizophrenia program. The update is framed as informational on pipeline direction rather than including any quantified efficacy, safety, or financial targets.